pI: 6.9063 |
Length (AA): 773 |
MW (Da): 89488 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_128386)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G40820 | serine/threonine-protein kinase ATR |
Babesia bovis | BBOV_III011480 | phosphatidylinositol 3- and 4-kinase family protein |
Brugia malayi | Bm1_22870 | Phosphatidylinositol 3- and 4-kinase family protein |
Candida albicans | CaO19.8870 | potential phosphatidylinositol kinase similar to S. cerevisiae MEC1 (YBR136W) involved in DNA repair and recombination |
Candida albicans | CaO19.1283 | potential phosphatidylinositol kinase similar to S. cerevisiae MEC1 (YBR136W) involved in DNA repair and recombination |
Caenorhabditis elegans | CELE_T06E4.3 | Protein ATL-1, isoform C |
Cryptosporidium hominis | Chro.40300 | hypothetical protein |
Cryptosporidium hominis | Chro.40299 | hypothetical protein |
Cryptosporidium hominis | Chro.40301 | ataxia telangiectasia and Rad3-related protein |
Cryptosporidium parvum | cgd4_2670 | FRP1 like protein involved in DNA repair with a FAT domain and a phosphatidylinositol kinase domain at the C-terminus |
Dictyostelium discoideum | DDB_G0291380 | ATR subfamily protein kinase |
Drosophila melanogaster | Dmel_CG4252 | meiotic 41 |
Echinococcus granulosus | EgrG_000457600 | phosphatidylinositol 3 and 4 kinase |
Entamoeba histolytica | EHI_197310 | Phosphatidylinositol 3- and 4-kinase family |
Echinococcus multilocularis | EmuJ_000457600 | phosphatidylinositol 3 and 4 kinase |
Homo sapiens | ENSG00000175054 | ATR serine/threonine kinase |
Leishmania braziliensis | LbrM.32.1620 | phosphatidylinositol 3-related kinase, putative |
Leishmania donovani | LdBPK_321520.1 | phosphatidylinositol 3-related kinase, putative |
Leishmania infantum | LinJ.32.1520 | phosphatidylinositol 3-related kinase, putative |
Leishmania major | LmjF.32.1460 | phosphatidylinositol 3-related kinase, putative |
Leishmania mexicana | LmxM.31.1460 | phosphatidylinositol 3-related kinase, putative |
Loa Loa (eye worm) | LOAG_06382 | hypothetical protein |
Loa Loa (eye worm) | LOAG_11558 | hypothetical protein |
Loa Loa (eye worm) | LOAG_08139 | phosphatidylinositol 3 |
Mus musculus | ENSMUSG00000032409 | ataxia telangiectasia and Rad3 related |
Neospora caninum | NCLIV_015320 | phosphatidylinositol 3- and 4-kinase domain- containing protein, putative |
Oryza sativa | 4342103 | Os06g0724700 |
Saccharomyces cerevisiae | YBR136W | Mec1p |
Schistosoma japonicum | Sjp_0077490 | ko:K06640 ataxia telangiectasia and Rad3 related, putative |
Schistosoma japonicum | Sjp_0075640 | hypothetical protein |
Schistosoma japonicum | Sjp_0122790 | Serine/threonine-protein kinase ATR, putative |
Schistosoma japonicum | Sjp_0112210 | Serine/threonine-protein kinase atr, putative |
Schistosoma mansoni | Smp_162340 | phosphatidylinositol 3-and 4-kinase |
Schmidtea mediterranea | mk4.015073.00 | |
Schmidtea mediterranea | mk4.013442.01 | |
Schmidtea mediterranea | mk4.024757.00 | |
Trypanosoma brucei gambiense | Tbg972.11.16460 | phosphatidylinositol 3-related kinase, putative |
Trypanosoma brucei | Tb927.11.14680 | phosphatidylinositol 3-related kinase, putative |
Trypanosoma cruzi | TcCLB.506223.120 | phosphatidylinositol 3-related kinase, putative |
Trypanosoma cruzi | TcCLB.511719.10 | phosphatidylinositol 3-related kinase, putative |
Trichomonas vaginalis | TVAG_178360 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_493750 | PIKK family atypical protein kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.6300 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.6300 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.6300 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.6300 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_T06E4.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
YBR136W | Saccharomyces cerevisiae | inviable | yeastgenome |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | ATR serine/threonine kinase | Compounds | References |